InvestorsHub Logo

MinnieM

11/03/17 3:23 PM

#202456 RE: BioHedge #202454

Actually, I don't even see it as 10 years. There was no real movement until Leo took over in 2011. First trial started in 2012. See this post.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=135932105

I agree that most investors don't have the patience for biotech investing and that we are now poised for some serious movement. ;)

Leo's done a great job getting things moving all things considered.

US trials (Brilacidin UP done outside US and not listed here):








In Reply to 'BioHedge'
I think a 100x return is a possibility but it will take time. We're about 10 years into IPIX's development and this is usually when you see big jumps in valuation which is inline with other heavily technology based companies. That timeline is getting shorter but it is pretty consistent in the VC world.

Most investors don't have the patients to wait that long and so very few should be investing in biotech. I think we'll see 1-3 deals in the next 90ish days which will take us to 1-2B in MC then if we get a moon-shot home run from K, P or additional indications of B then we may get a 100x return within 1-2 more years. I'll be happy with a 10x and over the moon with a 100x.